Synthesis and docking studies of new 5-bromoindole-2-carboxylic acid oxadiazole derivatives as EGFR inhibitors
Open Access
- 25 June 2023
- journal article
- research article
- Published by Tikrit University in Tikrit Journal of Pharmaceutical Sciences
- Vol. 17 (1) , 58-77
Abstract
The current study reports the design and synthesis of novel oxadiazole derivatives of 5-bromoindole-2-carboxylic acid and their molecular docking properties. In order to determine the structure of the new oxadiazole derivatives (3, 4a, 4b), a number of spectroscopic techniques (IR and 1HNMR) were employed. Molecular docking analysis indicated that compounds 3, 4a, 4b showed favorable binding free energy against the EGFR tyrosine kinase domain. None of these compounds appeared to suppress cytochrome P450, and all of them showed appropriate absorption levels. Moreover, they did not exhibit any hepatotoxicity when tested in vitro. Compound 4a Reported to have the highest stability, with a good net binding energy, and an excellent binding energy with hot amino acids. Dipole moment is also rather high. This result is an indication of compound 4a is with superior capacity to create hydrogen bonds over erlotinib. Likewise, compound 4a was found to be the most stable in its interaction with EGFR tyrosine kinase. Finally, molecular dynamic simulation revealed excellent outcomes for compound 4a.Keywords
This publication has 9 references indexed in Scilit:
- Indole-Containing Natural Products 2019–2022: Isolations, Reappraisals, Syntheses, and Biological ActivitiesMolecules, 2022
- New Pyrrole Derivatives as Promising Biological Agents: Design, Synthesis, Characterization, In Silico, and Cytotoxicity EvaluationInternational Journal of Molecular Sciences, 2022
- Cancer Immune Evasion Through Loss of MHC Class I Antigen PresentationFrontiers in Immunology, 2021
- Rethink of EGFR in Cancer With Its Kinase Independent Function on BoardFrontiers in Oncology, 2019
- Synthesis and antimicrobial evaluation with DFT study for new thiazole derivativesIraqi Journal of Pharmaceutical Sciences, 2018
- Epidermal Growth Factor Receptor Cell Proliferation Signaling PathwaysCancers, 2017
- Regulation of MAPKs by growth factors and receptor tyrosine kinasesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysisThe Lancet, 2002
- Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular DomainsCell, 2002